Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease

R. Kalla; A.T. Adams; D. Bergemalm; S. Vatn; N.A. Kennedy; P. Ricanek; J. Lindstrom; A. Ocklind; F. Hjelm; N.T. Ventham; G.T. Ho; C. Petren; D. Repsilber; J. Soderholm; M. Pierik; M. D'Amato; F. Gomollon; C. Olbjorn; J. Jahnsen; M.H. Vatn; J. Halfvarson; J. Satsangi; IBD Character Consortium

doi:10.1093/ecco-jcc/jjaa230

Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease

R. Kalla, A.T. Adams, D. Bergemalm, S. Vatn, N.A. Kennedy, P. Ricanek, J. Lindstrom, A. Ocklind, F. Hjelm, N.T. Ventham, G.T. Ho^*, C. Petren, D. Repsilber, J. Soderholm, M. Pierik, M. D'Amato, F. Gomollon, C. Olbjorn, J. Jahnsen, M.H. VatnJ. Halfvarson, J. Satsangi^*, IBD Character Consortium

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Web of Science)

Original language	English
Pages (from-to)	699-708
Number of pages	10
Journal	Journal of Crohn's & Colitis
Volume	15
Issue number	5
DOIs	https://doi.org/10.1093/ecco-jcc/jjaa230
Publication status	Published - 1 May 2021

Keywords

BIOMARKERS
CELLS
CHILDREN
Crohn's disease
FECAL CALPROTECTIN
GENOME-WIDE ASSOCIATION
OSM
PROGNOSIS
RISK
genetics
inflammatory bowel diseases [IBD]
outcomes
prognosis
protein quantitative trait loci
proteins
proximity extension assay
ulcerative colitis
THERAPY

Access to Document

10.1093/ecco-jcc/jjaa230

Cite this

Kalla, R., Adams, A. T., Bergemalm, D., Vatn, S., Kennedy, N. A., Ricanek, P., Lindstrom, J., Ocklind, A., Hjelm, F., Ventham, N. T., Ho, G. T., Petren, C., Repsilber, D., Soderholm, J., Pierik, M., D'Amato, M., Gomollon, F., Olbjorn, C., Jahnsen, J., ... IBD Character Consortium (2021). Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease. Journal of Crohn's & Colitis, 15(5), 699-708. https://doi.org/10.1093/ecco-jcc/jjaa230

Kalla, R. ; Adams, A.T. ; Bergemalm, D. ; Vatn, S. ; Kennedy, N.A. ; Ricanek, P. ; Lindstrom, J. ; Ocklind, A. ; Hjelm, F. ; Ventham, N.T. ; Ho, G.T. ; Petren, C. ; Repsilber, D. ; Soderholm, J. ; Pierik, M. ; D'Amato, M. ; Gomollon, F. ; Olbjorn, C. ; Jahnsen, J. ; Vatn, M.H. ; Halfvarson, J. ; Satsangi, J. ; IBD Character Consortium. / Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease. In: Journal of Crohn's & Colitis. 2021 ; Vol. 15, No. 5. pp. 699-708.

@article{104d03aecd4a430e8667d03a0f83a18f,

title = "Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease",

keywords = "BIOMARKERS, CELLS, CHILDREN, Crohn's disease, FECAL CALPROTECTIN, GENOME-WIDE ASSOCIATION, OSM, PROGNOSIS, RISK, genetics, inflammatory bowel diseases [IBD], outcomes, prognosis, protein quantitative trait loci, proteins, proximity extension assay, ulcerative colitis, THERAPY",

author = "R. Kalla and A.T. Adams and D. Bergemalm and S. Vatn and N.A. Kennedy and P. Ricanek and J. Lindstrom and A. Ocklind and F. Hjelm and N.T. Ventham and G.T. Ho and C. Petren and D. Repsilber and J. Soderholm and M. Pierik and M. D'Amato and F. Gomollon and C. Olbjorn and J. Jahnsen and M.H. Vatn and J. Halfvarson and J. Satsangi and {IBD Character Consortium}",

year = "2021",

month = may,

day = "1",

doi = "10.1093/ecco-jcc/jjaa230",

language = "English",

volume = "15",

pages = "699--708",

journal = "Journal of Crohn's & Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

number = "5",

}

Kalla, R, Adams, AT, Bergemalm, D, Vatn, S, Kennedy, NA, Ricanek, P, Lindstrom, J, Ocklind, A, Hjelm, F, Ventham, NT, Ho, GT, Petren, C, Repsilber, D, Soderholm, J, Pierik, M, D'Amato, M, Gomollon, F, Olbjorn, C, Jahnsen, J, Vatn, MH, Halfvarson, J, Satsangi, J & IBD Character Consortium 2021, 'Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease', Journal of Crohn's & Colitis, vol. 15, no. 5, pp. 699-708. https://doi.org/10.1093/ecco-jcc/jjaa230

Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease. / Kalla, R.; Adams, A.T.; Bergemalm, D.; Vatn, S.; Kennedy, N.A.; Ricanek, P.; Lindstrom, J.; Ocklind, A.; Hjelm, F.; Ventham, N.T.; Ho, G.T.; Petren, C.; Repsilber, D.; Soderholm, J.; Pierik, M.; D'Amato, M.; Gomollon, F.; Olbjorn, C.; Jahnsen, J.; Vatn, M.H.; Halfvarson, J.; Satsangi, J.; IBD Character Consortium.

In: Journal of Crohn's & Colitis, Vol. 15, No. 5, 01.05.2021, p. 699-708.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease

AU - Kalla, R.

AU - Adams, A.T.

AU - Bergemalm, D.

AU - Vatn, S.

AU - Kennedy, N.A.

AU - Ricanek, P.

AU - Lindstrom, J.

AU - Ocklind, A.

AU - Hjelm, F.

AU - Ventham, N.T.

AU - Ho, G.T.

AU - Petren, C.

AU - Repsilber, D.

AU - Soderholm, J.

AU - Pierik, M.

AU - D'Amato, M.

AU - Gomollon, F.

AU - Olbjorn, C.

AU - Jahnsen, J.

AU - Vatn, M.H.

AU - Halfvarson, J.

AU - Satsangi, J.

AU - IBD Character Consortium

PY - 2021/5/1

Y1 - 2021/5/1

KW - BIOMARKERS

KW - CELLS

KW - CHILDREN

KW - Crohn's disease

KW - FECAL CALPROTECTIN

KW - GENOME-WIDE ASSOCIATION

KW - OSM

KW - PROGNOSIS

KW - RISK

KW - genetics

KW - inflammatory bowel diseases [IBD]

KW - outcomes

KW - prognosis

KW - protein quantitative trait loci

KW - proteins

KW - proximity extension assay

KW - ulcerative colitis

KW - THERAPY

U2 - 10.1093/ecco-jcc/jjaa230

DO - 10.1093/ecco-jcc/jjaa230

M3 - Article

C2 - 33201212

VL - 15

SP - 699

EP - 708

JO - Journal of Crohn's & Colitis

JF - Journal of Crohn's & Colitis

SN - 1873-9946

IS - 5

ER -